Physician profile
Luis R Hoyos Martinez
NPI 1013354042
$4,813.94
in general payments reported to CMS, 2019-2025
7 companies · $4,455 in 2025
The $4,455 reported for 2025 was more than what 95% of Reproductive Endocrinology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.27 · 2022: $138 · 2023: $60.33 · 2024: $145 · 2025: $4,455.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,795 · Food and Beverage: $1,665 · Consulting Fee: $1,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,795.35 |
| Food and Beverage | $1,664.75 |
| Consulting Fee | $1,200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Granata Bio Corporation | $2,277.93 | 2025 | |
| Ibsa Institut Biochimique Sa | $2,126.21 | 2025 | |
| Ferring Pharmaceuticals INC. | $190.42 | 2021-2023 | Menopur |
| Emd Serono, INC. | $137.97 | 2022-2025 | |
| Organon LLC | $32.90 | 2024 | |
| Hologic Sales and Service, LLC | $25.26 | 2025 | Myosure Tissue Removal Device |
| Galderma Laboratories, L.P. | $23.25 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Hoyos Martinez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.